<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Cipher Pharmaceuticals Inc — News on 6ix</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc</link>
<description>Latest news and press releases for Cipher Pharmaceuticals Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 29 Apr 2026 21:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/cipher-pharmaceuticals-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835f84978dffbe2df1306b5.webp</url>
<title>Cipher Pharmaceuticals Inc</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc</link>
</image>
<item>
<title>Cipher Pharmaceuticals Schedules Q1 2026 Earnings Release and Conference Call</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q1-2026-earnings-release-and-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q1-2026-earnings-release-and-conference-call</guid>
<pubDate>Wed, 29 Apr 2026 21:00:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the first quarter of 2026 after the market close on Thursday, May 7, 2026. The Company will also hold a conference call on Friday, May 8, 2026 at 8:30am ET to discuss the results and corporate developments.</description>
</item>
<item>
<title>Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-reports-fourth-quarter-results-and-full-year-2025-record-revenue-and-earnings</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-reports-fourth-quarter-results-and-full-year-2025-record-revenue-and-earnings</guid>
<pubDate>Thu, 12 Mar 2026 21:00:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earni...</description>
</item>
<item>
<title>Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q4-and-fiscal-2025-earnings-release-and-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q4-and-fiscal-2025-earnings-release-and-conference-call</guid>
<pubDate>Wed, 04 Mar 2026 22:00:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Schedules Q4 &amp; Fiscal 2025 Earnings Release and Conference Call ...</description>
</item>
<item>
<title>Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba™ (Spinosad)</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-announces-health-canadas-133000044</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-announces-health-canadas-133000044</guid>
<pubDate>Wed, 28 Jan 2026 13:30:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that Health Canada has accepted for review Cipher's new drug submission ("NDS") for Natroba™ (Spinosad), for the treatment of head lice and scabies.</description>
</item>
<item>
<title>Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba(TM) (Spinosad)</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-announces-health-canadas-acceptance-for-review-of-new-drug-submission-for-natrobatm-spinosad</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-announces-health-canadas-acceptance-for-review-of-new-drug-submission-for-natrobatm-spinosad</guid>
<pubDate>Wed, 28 Jan 2026 13:30:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for...</description>
</item>
<item>
<title>Cipher Pharmaceuticals Reports Third Quarter 2025 Results</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-reports-third-quarter-2025-results</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-reports-third-quarter-2025-results</guid>
<pubDate>Thu, 06 Nov 2025 22:00:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Reports Third Quarter 2025 Results Canada NewsWire (All figu...</description>
</item>
<item>
<title>Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q3-2025-earnings-release-and-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q3-2025-earnings-release-and-conference-call</guid>
<pubDate>Wed, 29 Oct 2025 21:00:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call Canada News...</description>
</item>
<item>
<title>Cipher Pharmaceuticals Receives Successful Arbitration Award</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-receives-successful-arbitration-award</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-receives-successful-arbitration-award</guid>
<pubDate>Tue, 14 Oct 2025 11:45:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Receives Successful Arbitration Award Canada NewsWire MISS...</description>
</item>
<item>
<title>Cipher Pharmaceuticals Announces the Passing of Director Mr. Harold Wolkin</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-announces-the-passing-of-director-mr-harold-wolkin</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-announces-the-passing-of-director-mr-harold-wolkin</guid>
<pubDate>Tue, 26 Aug 2025 21:00:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Announces the Passing of Director Mr. Harold Wolkin Canada NewsW...</description>
</item>
<item>
<title>Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-reports-second-quarter-2025-results-including-record-revenue</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-reports-second-quarter-2025-results-including-record-revenue</guid>
<pubDate>Thu, 07 Aug 2025 21:35:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue Ca...</description>
</item>
<item>
<title>Cipher Pharmaceuticals Schedules Q2 2025 Earnings Release and Conference Call</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q2-2025-earnings-release-and-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q2-2025-earnings-release-and-conference-call</guid>
<pubDate>Tue, 29 Jul 2025 15:28:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Schedules Q2 2025 Earnings Release and Conference Call Canada Ne...</description>
</item>
<item>
<title>Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-announces-results-of-annual-and-special-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-announces-results-of-annual-and-special-meeting-of-shareholders</guid>
<pubDate>Fri, 13 Jun 2025 16:18:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders ...</description>
</item>
<item>
<title>Cipher Pharmaceuticals Reports First Quarter 2025 Results, and Announces $15 Million Debt Repayment</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-reports-first-quarter-2025-results-and-announces-dollar15-million-debt-repayment</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-reports-first-quarter-2025-results-and-announces-dollar15-million-debt-repayment</guid>
<pubDate>Thu, 08 May 2025 21:00:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Reports First Quarter 2025 Results, and Announces $15 Million Debt Repayme...</description>
</item>
<item>
<title>Cipher Pharmaceuticals Schedules Q1 2025 Earnings Release and Conference Call</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q1-2025-earnings-release-and-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q1-2025-earnings-release-and-conference-call</guid>
<pubDate>Fri, 02 May 2025 20:05:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Schedules Q1 2025 Earnings Release and Conference Call Canada Ne...</description>
</item>
<item>
<title>Cipher Pharmaceuticals Announces Normal Course Issuer Bid, Including Intention to Utilize Block Purchases</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-announces-normal-course-issuer-bid-including-intention-to-utilize-block-purchases</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-announces-normal-course-issuer-bid-including-intention-to-utilize-block-purchases</guid>
<pubDate>Thu, 01 May 2025 11:00:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Announces Normal Course Issuer Bid, Including Intention to Utilize Block P...</description>
</item>
<item>
<title>Cipher Pharmaceuticals Secures Medicaid Step-Through Preferred Status for Natroba(TM) in the state of Illinois</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-secures-medicaid-step-through-preferred-status-for-natrobatm-in-the-state-of-illinois</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-secures-medicaid-step-through-preferred-status-for-natrobatm-in-the-state-of-illinois</guid>
<pubDate>Tue, 29 Apr 2025 11:00:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Secures Medicaid Step-Through Preferred Status for Natroba&#x2122; in the ...</description>
</item>
<item>
<title>Cipher Pharmaceuticals Secures Medicaid Step-Through Preferred Status for Natroba™ in the state of Illinois</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-secures-medicaid-step-110000005</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-secures-medicaid-step-110000005</guid>
<pubDate>Tue, 29 Apr 2025 11:00:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") proudly announces the state of Illinois has updated its Preferred Drug Listing ("PDL") where Cipher's product Natroba™, for the treatment of scabies and head lice, has obtained preferred drug status on Medicaid state plans, and whereby its main competitive product Permethrin 5% has been downgraded to non-preferred status. As a result of this change, all Medicaid treatments for scabies and Permethrin 5% prescription</description>
</item>
<item>
<title>Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-reports-fourth-quarter-and-full-year-2024-results</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-reports-fourth-quarter-and-full-year-2024-results</guid>
<pubDate>Tue, 18 Mar 2025 21:30:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results Canada NewsWir...</description>
</item>
<item>
<title>Cipher Pharmaceuticals Schedules Q4 & Fiscal 2024 Earnings Release and Conference Call</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q4-and-fiscal-2024-earnings-release-and-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q4-and-fiscal-2024-earnings-release-and-conference-call</guid>
<pubDate>Tue, 11 Mar 2025 21:00:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Schedules Q4 &amp; Fiscal 2024 Earnings Release and Conference Call ...</description>
</item>
<item>
<title>Cipher Pharmaceuticals Partner Moberg Pharma AB Reports Topline Data in MOB-015 Phase 3 Study</title>
<link>https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-partner-moberg-pharma-ab-reports-topline-data-in-mob-015-phase-3-study</link>
<guid isPermaLink="true">https://6ix.com/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-partner-moberg-pharma-ab-reports-topline-data-in-mob-015-phase-3-study</guid>
<pubDate>Tue, 10 Dec 2024 22:43:00 GMT</pubDate>
<description>Cipher Pharmaceuticals Partner Moberg Pharma AB Reports Topline Data in MOB-015 Phase 3 Study ...</description>
</item>
</channel>
</rss>